IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
179.56
+2.87 (1.62%)
At close: Sep 26, 2025, 4:00 PM EDT
181.87
+2.31 (1.29%)
After-hours: Sep 26, 2025, 7:28 PM EDT
IQVIA Holdings Revenue
IQVIA Holdings had revenue of $4.02B in the quarter ending June 30, 2025, with 5.32% growth. This brings the company's revenue in the last twelve months to $15.70B, up 3.60% year-over-year. In the year 2024, IQVIA Holdings had annual revenue of $15.41B with 2.81% growth.
Revenue (ttm)
$15.70B
Revenue Growth
+3.60%
P/S Ratio
2.03
Revenue / Employee
$178,409
Employees
88,000
Market Cap
30.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15.41B | 421.00M | 2.81% |
Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
IQV News
- 1 day ago - ILMN Stock vs. IQV Stock - Forbes
- 11 days ago - IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships - Business Wire
- 16 days ago - IQVIA: A Positive Long-Term Outlook Despite Trump Legislation - Seeking Alpha
- 17 days ago - IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management - Business Wire
- 25 days ago - IQVIA names Michael Fedock as financial chief - Reuters
- 25 days ago - IQVIA Announces CFO Transition in Early 2026 - Business Wire
- 4 weeks ago - IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies - PRNewsWire
- 5 weeks ago - IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes - Business Wire